Simplex Quantum, a Tokyo-based medical technology startup specializing in AI-driven heart health solutions, has been selected as one of 20 high-potential startups for the prestigious MedTech Innovator Asia Pacific 2025 Accelerator Program.
MedTech Innovator is the world's largest accelerator of medical technology companies, aiming to improve human health by accelerating the growth of companies transforming patient care. The Asia Pacific program connects best-in-class startups with investors, business leaders, and service professionals in the medtech industry to drive the commercialization of life-changing technologies in the region.
This year, over 550 companies applied for the Asia Pacific program. After a rigorous selection process, 60 companies were invited to pitch, and 20 were chosen for the 2025 cohort. The selected companies will participate in a four-month accelerator program, culminating in the MedTech Innovator Asia Pacific Showcase and Grand Finals in Singapore at the end of October.
"We are honored to be part of the MedTech Innovator Asia Pacific 2025 cohort," said Ryu Saito, CEO of Simplex Quantum. "This opportunity validates our commitment to transforming heart failure detection and management with scalable, AI-driven solutions. We look forward to leveraging this platform to forge strategic partnerships and expand our impact across Asia and beyond."
Comments powered by CComment